Expired Canadian patentCanada
Colorectal cancer prognostics
CA 2464894 C · Owner: Veridex, Llc · Inventors: Wang, Yixin
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of providing a prognosis of colorectal cancer is conducted by analyzing the , expression of a group of genes. Gene expresson profiles in a variety of medium such as , microarrays are included as are kits that contain them.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 2004 and granted February 11, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 30, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 30, 2004
GrantedFebruary 11, 2014
Term endedMarch 30, 2024
Patent numberCA 2464894 C
Classification (IPC)C12Q1/04 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.